Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Evaluation of the toxic effect of endocrine disruptor Bisphenol A (BPA) in the acute and chronic toxicity tests with Pomacea lineata gastropod.

de Andrade ALC, Soares PRL, da Silva SCBL, da Silva MCG, Santos TP, Cadena MRS, Soares PC, Cadena PG.

Comp Biochem Physiol C Toxicol Pharmacol. 2017 Jul;197:1-7. doi: 10.1016/j.cbpc.2017.04.002. Epub 2017 Apr 6.

PMID:
28392374
2.

Clinical performance of a novel ultrathin strut, low-dose, sirolimus-eluting stent with abluminal-only biodegradable polymeric coating for patients undergoing percutaneous coronary intervention in the daily practice.

Prado GF Jr, Ribeiro EE, Melo PH, Pinton FA, Esteves-Filho A, Takimura CK, Mariani J Jr, Kajita LJ, Marchiori G, Araripe Falcao Bde A, Galon MZ, Soares PR, Zalc S, Lemos PA.

Cardiovasc Diagn Ther. 2015 Dec;5(6):414-9. doi: 10.3978/j.issn.2223-3652.2015.07.07.

3.

A Novel Algorithm to Quantify Coronary Remodeling Using Inferred Normal Dimensions.

Falcão BA, Falcão JL, Morais GR, Silva RC, Lopes AC, Soares PR, Mariani J Jr, Kalil-Filho R, Edelman ER, Lemos PA.

Arq Bras Cardiol. 2015 Oct;105(4):390-8. doi: 10.5935/abc.20150098. Epub 2015 Aug 18. English, Portuguese.

4.

A Novel Algorithm to Quantify Coronary Remodeling Using Inferred Normal Dimensions.

Falcão BA, Falcão JL, Morais GR, Silva RC, Lopes AC, Soares PR, Mariani J Jr, Kalil-Filho R, Edelman ER, Lemos PA.

Arq Bras Cardiol. 2015 Aug 18. pii: S0066-782X2015005050098. [Epub ahead of print] Portuguese, English.

5.

Long-term follow-up of a randomized, controlled clinical trial of three therapeutic strategies for multivessel stable coronary artery disease in women.

Mansur Ade P, Hueb WA, Takada JY, Avakian SD, Soares PR, Garzilo CL, Kalil Filho R, Ramires JA.

Interact Cardiovasc Thorac Surg. 2014 Dec;19(6):997-1001. doi: 10.1093/icvts/ivu288. Epub 2014 Sep 2.

PMID:
25183741
6.

Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial.

Lima EG, Hueb W, Garcia RM, Pereira AC, Soares PR, Favarato D, Garzillo CL, D'Oliveira Vieira R, Rezende PC, Takiuti M, Girardi P, Hueb AC, Ramires JA, Kalil Filho R.

Am Heart J. 2013 Aug;166(2):250-7. doi: 10.1016/j.ahj.2013.04.017. Epub 2013 Jun 15.

PMID:
23895807
7.

Long-term analysis of left ventricular ejection fraction in patients with stable multivessel coronary disease undergoing medicine, angioplasty or surgery: 10-year follow-up of the MASS II trial.

Garzillo CL, Hueb W, Gersh BJ, Lima EG, Rezende PC, Hueb AC, Vieira RD, Favarato D, Pereira AC, Soares PR, Serrano CV Jr, Ramires JA, Kalil Filho R.

Eur Heart J. 2013 Nov;34(43):3370-7. doi: 10.1093/eurheartj/eht201. Epub 2013 Jul 4.

PMID:
23828828
8.

Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trial.

Vieira RD, Hueb W, Gersh BJ, Lima EG, Pereira AC, Rezende PC, Garzillo CL, Hueb AC, Favarato D, Soares PR, Ramires JA, Kalil Filho R.

Circulation. 2012 Sep 11;126(11 Suppl 1):S158-63.

9.

Cost-effectiveness analysis for surgical, angioplasty, or medical therapeutics for coronary artery disease: 5-year follow-up of medicine, angioplasty, or surgery study (MASS) II trial.

Vieira RD, Hueb W, Hlatky M, Favarato D, Rezende PC, Garzillo CL, Lima EG, Soares PR, Hueb AC, Pereira AC, Ramires JA, Kalil Filho R.

Circulation. 2012 Sep 11;126(11 Suppl 1):S145-50.

10.

Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial.

Hueb W, Gersh BJ, Rezende PC, Garzillo CL, Lima EG, Vieira RD, Garcia RM, Favarato D, Segre CA, Pereira AC, Soares PR, Ribeiro E, Lemos P, Perin MA, Strunz CC, Dallan LA, Jatene FB, Stolf NA, Hueb AC, Dias R, Gaiotto FA, da Costa LM, Oikawa FT, de Melo RM, Serrano CV Jr, de Ávila LF, Villa AV, Filho JR, Nomura C, Ramires JA, Kalil Filho R; MASS-V Study Group.

BMC Cardiovasc Disord. 2012 Aug 16;12:65. doi: 10.1186/1471-2261-12-65.

11.

In vitro antiproliferative effects of the indole alkaloid vallesiachotamine on human melanoma cells.

Soares PR, de Oliveira PL, de Oliveira CM, Kato L, Guillo LA.

Arch Pharm Res. 2012 Mar;35(3):565-71. doi: 10.1007/s12272-012-0320-7. Epub 2012 Apr 5.

PMID:
22477204
12.

Comparing the performance of rat lungs preserved for 6 or 12 hours after perfusion with low-potassium dextran or histidine-tryptophan-ketoglutarate.

Simões EA, Pêgo-Fernandes PM, Cardoso PF, Pazetti R, Werebe E, de Oliveira Braga KA, Menezes A, Nepomuceno N, Soares PR, Correia AT, Jatene FB.

Transplant Proc. 2011 Jun;43(5):1520-4. doi: 10.1016/j.transproceed.2010.12.001.

PMID:
21693228
13.

Magnetic field-magnetic nanoparticle culture system used to grow in vitro murine embryonic stem cells.

de Freitas ER, Soares PR, de Santos RP, dos Santos RL, Porfírio EP, Báo SN, Lima EC, Guillo LA.

J Nanosci Nanotechnol. 2011 Jan;11(1):36-44.

PMID:
21446404
14.

Comparison between Perfadex and locally manufactured low-potassium dextran solution for pulmonary preservation in an ex vivo isolated lung perfusion model.

Soares PR, Braga KA, Nepomuceno NA, Pazetti R, Correia AT, Cardoso PF, Bisceglijatene F, Pêgo-Fernandes PM.

Transplant Proc. 2011 Jan-Feb;43(1):84-8. doi: 10.1016/j.transproceed.2010.12.005.

15.

Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery.

Borges JC, Lopes N, Soares PR, Góis AF, Stolf NA, Oliveira SA, Hueb WA, Ramires JA.

J Cardiothorac Surg. 2010 Oct 26;5:91. doi: 10.1186/1749-8090-5-91.

16.

Hypotheses, rationale, design, and methods for prognostic evaluation in type 2 diabetic patients with angiographically normal coronary arteries. The MASS IV-DM Trial.

Hueb W, Lopes N, Soares PR, Gersh BJ, Lima EG, Vieira RD, Garzillo CL, Garcia RR, Pereira AC, Strunz CM, Meneguetti C, Tsutsui J, Parga J, Lemos P, Hueb A, Ushida A, Maranhão R, Chamone DA, Ramires JA.

BMC Cardiovasc Disord. 2010 Sep 29;10:47. doi: 10.1186/1471-2261-10-47.

17.

Five-year follow-up of a randomized comparison between off-pump and on-pump stable multivessel coronary artery bypass grafting. The MASS III Trial.

Hueb W, Lopes NH, Pereira AC, Hueb AC, Soares PR, Favarato D, Vieira RD, Lima EG, Garzillo CL, Paulitch Fda S, César LA, Gersh BJ, Ramires JA.

Circulation. 2010 Sep 14;122(11 Suppl):S48-52. doi: 10.1161/CIRCULATIONAHA.109.924258.

18.

Experimental model of isolated lung perfusion in rats: technique and application in lung preservation studies.

Pêgo-Fernandes PM, Werebe Ede C, Cardoso PF, Pazetti R, Oliveira KA, Soares PR, Jatene FB.

J Bras Pneumol. 2010 Jul-Aug;36(4):490-3. English, Portuguese.

19.

Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.

Hueb W, Lopes N, Gersh BJ, Soares PR, Ribeiro EE, Pereira AC, Favarato D, Rocha AS, Hueb AC, Ramires JA.

Circulation. 2010 Sep 7;122(10):949-57. doi: 10.1161/CIRCULATIONAHA.109.911669. Epub 2010 Aug 23.

20.

Experimental model of isolated lung perfusion in rats: first Brazilian experience using the IL-2 isolated perfused rat or guinea pig lung system.

Pêgo-Fernandes PM, Werebe E, Cardoso PF, Pazetti R, de Oliveira KA, Soares PR, Jatene FB.

Transplant Proc. 2010 Mar;42(2):444-7. doi: 10.1016/j.transproceed.2010.01.016.

PMID:
20304160

Supplemental Content

Loading ...
Support Center